You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華仁藥業(300110.SZ):永裕恆豐擬減持不超1182.21萬股
格隆匯 05-14 19:36

格隆匯5月14日丨華仁藥業(300110.SZ)公佈,永裕恆豐投資管理有限公司(“永裕恆豐”)20201023日發布了《關於持股5%以上股東減持股份預披露公吿》,計劃自減持計劃公吿之日起十五個交易日後的六個月內通過集中競價交易或大宗交易方式減持華仁藥業股份數量累計不超過1182.21萬股(不超過公司總股本的1%)(“前次減持計劃”)截至2021514日,永裕恆豐前次減持計劃已實施完畢,減持計劃期限內減持數量為0

永裕恆豐計劃自公吿之日起15個交易日後的六個月內,擬通過證券交易所集中競價交易或大宗交易方式減持華仁藥業股份數量不超過1182.21萬股,不超過公司總股本的1%若此期間公司有送股、資本公積金轉增股本等股份變動事項,則對該減持數量進行相應調整,減持價格視市場情況確定。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account